Eternal Peptides review

A storefront we could not reach

Eternal Peptides is a US research peptide brand whose storefront, eternalpeptides.com, returned HTTP 503 with a Retry-After header of one day when we tried to load it on October 19, 2026. That single fact shapes this entire review. Every field we would normally fill from a supplier’s own pages, the certificate library, the laboratory, the test methods, the catalog, the prices, the shipping terms, the payment methods, the return policy, the contact details and the research-use disclaimer, is unverified. What follows comes from two outside sources: Peptide Protocol Wiki, a vendor directory, and Finnrick, an independent testing aggregator that has both tested the brand’s products and written an intelligence report on the company. We attribute each fact to its source and we do not present any of it as our own finding.

The brand, according to Finnrick, began showing signals in 2024, and the .com domain was captured and offered for sale in July 2025 before becoming the store. A lookalike domain, eternalpep.com, also exists. The one thing a reader should know is that the independent test record for this company is among the weaker ones we have seen, and that nothing from the company itself was available to set against it.

What the outside record says about testing

Peptide Protocol Wiki reports that Eternal Peptides posts third-party certificates from Janoshik Analytical on its product pages and that they open without an account. If that is accurate, it would be a reasonable practice. We could not confirm it, because the pages were unreachable, so we leave the laboratory out of the confirmed record and mark the certificate library as unknown. Finnrick adds that an earlier version of the lab-tests page exposed WordPress admin edit URLs, which is a housekeeping failure rather than a testing one, but it does not inspire confidence in how the page was maintained.

Finnrick’s own tests are the substance of the matter. Across 28 samples, Finnrick recorded 10 passes and 18 fails. BPC-157 was tested 10 times and rated at 37 percent, with the most recent result a fail on September 15, 2026. A July 2026 Finnrick report showed two GLP-class items at 0 passes in 4 tests each. Other items did better: one GLP-class item rated 75 percent, another 70 percent, and Melanotan II 70 percent. Taken together, Finnrick’s numbers place the brand in the lower part of its table, and the product a buyer is most likely to order, BPC-157, is the one that failed most often.

In practice, that means a buyer has outside evidence that lots sold under this name have repeatedly not matched their labels, and no company document to weigh against it. A posted Janoshik certificate, if it exists, describes the lot the company chose to publish. Finnrick’s results describe the lots that reached buyers.

Two further points from Finnrick’s report bear on how much weight the posted certificates would carry even if we could read them. First, Finnrick’s data shows that the brand’s results have moved over time, with earlier passes on some items and later fails on others, which is consistent with inconsistent sourcing rather than with a single bad batch. Second, the brand’s claim on social media to hold the top position in Finnrick’s own table is, by Finnrick’s account, contradicted by the data, which means the company has described its independent test record in a way the independent tester does not recognize. A buyer who reads a posted certificate on this site should keep both facts in mind.

We should also be clear about the limits of what a 503 response tells us. A temporary outage with a one-day retry header is not evidence that a company has closed, and we do not record Eternal Peptides as closed. It is evidence only that, on the day we checked, nothing on the company’s own site could be read, and that a buyer who tried to order that day could not have done so either.

The company, the policies and the promotion

Finnrick identifies the legal entity as Cenvira LLC in New York, with a ZIP code of 11362, through the brand’s terms, DBA and trademark filings. That is more corporate identification than many suppliers volunteer, and it is to the company’s credit that the trail exists, even though the wiki reports that the site itself does not disclose a location. No street address or phone number is recorded. A support email is listed by Finnrick but unverified.

The wiki describes about 23 products, including BPC-157, Epitalon, GHK-Cu, Ipamorelin, MOTS-C, PT-141, Sermorelin and TB-500, plus GLP-class items. It reports US-only shipping by USPS Priority Mail in two to four business days, free from $200, and card as the only payment method. Finnrick adds that payment moved from Zelle, CashApp and Bitcoin to card processing over the brand’s life, a shift toward methods that give buyers chargeback protection. No prices, return terms or guarantees could be recorded.

On trust, the picture is poor. Trustpilot has removed the company’s profile with its standard notice that it violated the platform’s guidelines. Finnrick reports undisclosed promotional placements on Reddit and Quora, and a social media claim that the brand held the top position in Finnrick’s own rankings, which Finnrick says its data contradicts. We found no FDA warning letter naming the company.

Bottom line

Eternal Peptides could not be assessed on its own documents, and the documents that exist elsewhere do not help it. Finnrick’s 28 independent tests failed more often than they passed, BPC-157 failed most of all, the Trustpilot profile is gone, and the company has been reported promoting itself without disclosure and overstating its standing. The one solid point in its favor is that a legal entity can be identified. If the storefront returns and the certificates the wiki describes can be read, we will reassess. Until then, a buyer looking for BPC-157 has outside evidence against this brand and nothing from the brand itself in reply, and should order from a supplier whose certificates can actually be opened.